|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1996-1-4
|
|
pubmed:abstractText |
The feasibility of adjuvant cisplatin, methotrexate and vinblastine chemotherapy was evaluated in Taiwanese patients with invasive transitional cell carcinoma at high risk for recurrence.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
155
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
118-21
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7490806-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7490806-Carcinoma, Transitional Cell,
pubmed-meshheading:7490806-Chemotherapy, Adjuvant,
pubmed-meshheading:7490806-Cisplatin,
pubmed-meshheading:7490806-Disease-Free Survival,
pubmed-meshheading:7490806-Female,
pubmed-meshheading:7490806-Follow-Up Studies,
pubmed-meshheading:7490806-Humans,
pubmed-meshheading:7490806-Kidney Neoplasms,
pubmed-meshheading:7490806-Male,
pubmed-meshheading:7490806-Methotrexate,
pubmed-meshheading:7490806-Middle Aged,
pubmed-meshheading:7490806-Neoplasm Invasiveness,
pubmed-meshheading:7490806-Neoplasm Recurrence, Local,
pubmed-meshheading:7490806-Risk Factors,
pubmed-meshheading:7490806-Time Factors,
pubmed-meshheading:7490806-Ureteral Neoplasms,
pubmed-meshheading:7490806-Urinary Bladder Neoplasms,
pubmed-meshheading:7490806-Vinblastine
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
|
|
pubmed:affiliation |
Department of Medicine, Veterans General Hospital-Taipei, Taiwan, Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
